Pharmaceutical / Drug Definition :
Lowers blood glucose level by stimulating insulin release from pancreas, increasing insulin sensitivity at receptor sites, and decreasing hepatic glucose production. Also increases peripheral tissue sensitivity to insulin and causes mild diuresis.
Glimepiride (Glimepiride Entry Refusal)
General U.S. Food and Drug Administration Guidelines for:
- Manufacturers Glimepiride (Glimepiride Suppliers)
- Processors Glimepiride
- Repackers Glimepiride
- Relabelers Glimepiride
- Exporters Glimepiride
- Importers Glimepiride
For more information about Glimepiride, simply click below:
U.S. FDA Regulations:
U.S. FDA Regulation: 21 C.F.R. Part 207
Registrar Corp assists businesses with U.S. FDA compliance. Certificates of Registration issued by Registrar Corp provide confirmation to industry that you are fulfilling U.S. FDA registration requirements. U.S. FDA does not issue or recognize Certificates of Registration. Registrar Corp is not affiliated with the U.S. Food and Drug Administration.